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Abstract
The effects of 2-mercapto-1-(L-4-pyridethyl) benzimidazole (MPB), one of the benzimidazole derivatives designed for a
nucleic acid analogue, on melanogenesis of murine B16-F10 melanoma cell lines were investigated. MPB (40 WM) induced a
striking dendricity in B16 melanoma cells within 12 h and maximal dendricity between 48 and 72 h. The stimulation of
melanin synthesis was observed after only 2 days of treatment together with a dose-dependent growth inhibition. Moreover,
MPB increased the activity of tyrosinase through the expression of tyrosinase mRNA without increasing the intracellular
cyclic AMP content. MPB-induced melanogenesis was inhibited by novel protein kinase A inhibitors, KT-5720 and H-85.
These findings indicate that MPB stimulated B16 cells to terminally differentiate and may be a useful drug in studying the
regulation of melanogenesis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The established murine B16 melanoma cell line
o¡ers a model system with readily quanti¢able
markers of di¡erentiation such as melanin formation
(melanogenesis) and dendrite-like structure forma-
tion. These markers are characteristic of normal dif-
ferentiating melanocytes [1^4], so B16 melanoma
cells represent a useful model for investigating di¡er-
entiation in solid tumors.
K-Melanocyte stimulating hormone (MSH) is well
known to target the B16 melanoma cells, inducing
melanogenesis [5]. Moreover, it has been shown
that MSH-induced melanogenesis in mouse melano-
ma cells occurs by an increase of intracellular cyclic
AMP (cAMP) content, an accumulation of tyrosi-
nase mRNA and a stimulation of tyrosinase activity
[6]. In addition to MSH, there are several non-phys-
iological compounds that stimulate melanogenesis.
Of those, imidazole compounds act di¡erently to
MSH and stimulate the activity of tyrosinase by in-
duction of de novo synthesis of the enzyme [7] with-
out the increase of cAMP in B16 cells [8]. Wong et
al. [9] have reported that bis-benzimidazole deriva-
tives, induce a highly dendritic morphology, in-
creased tyrosinase activity and tyrosinase mRNA in
the MM96E human melanoma cell line. These com-
pounds were found to have the most potent inhibi-
tory e¡ect on the a⁄nity of octamer binding proteins
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for the ATGCAAAT consensus sequence located in
the promoter region of certain genes associated with
proliferation and di¡erentiation.
2-Mercapto-1-(L-4-pyridethyl) benzimidazole
(MPB), the main compound of this study, is one of
the imidazole derivatives which was designed as a
nucleic acid analogue and shows anti-viral activity
through the inhibition of rRNA synthesis [10^12].
In the present study, we tested the e¡ects of MPB
on the di¡erentiation of B16-F10 melanoma cells.
We found that MPB induces dendrite formation
and promotes melanogenesis through the induction
of tyrosinase mRNA with the inhibition of cell
growth.
2. Materials and methods
2.1. Chemicals
MPB (Fig. 1) was provided by courtesy of Dr.
G.C. Mueller (McArdle Laboratory for Cancer Re-
search, University of Wisconsin, WI, USA). MPB as
a stock solution (1.2^4 mM in dimethyl sulfoxide
(DMSO)) was added to culture medium to the de-
sired concentrations with a ¢nal DMSO concentra-
tion of 0.1%. Protein kinase inhibitors, H-85, H-89
and H-7, were obtained from Seikagaku Co. (Tokyo,
Japan) and KT-5720 from Kyowa Medex Co., Ltd.
(Tokyo, Japan).
2.2. Cell cultures
The murine melanoma cell line B16-F10 (B16 cells)
was subcultured in minimum essential medium
(MEM; Flow Laboratories, McLean, VA, USA)
supplemented with 10% fetal bovine serum (FBS;
Filtron, Altona, Australia) and 1% non-essential
amino acids (NEAA; Flow Laboratories). Penicillin
(100 IU/ml) and streptomycin (100 Wg/ml) were
added to the media. B16 cells were passaged in T-
150 £asks (Falcon No. 3024, Becton-Dickinson and
Company, Lincoln Park, NJ, USA) at 37‡C in a
humidi¢ed atmosphere containing 5% CO2.
2.3. Assay of melanin content
The B16 cells (2U103) were plated on 24-well mul-
ti-dishes (Falcon, No. 3047). After cell attachment
(24 h) quadruplicate cultures were subjected to vari-
ous concentrations of MPB, and control cultures
were treated with 0.1% DMSO. The cells were then
incubated for 96 h at 37‡C with or without protein
kinase inhibitors. Media were changed 48 h after
addition of the drugs. Intracellular melanin was mea-
sured by the method of Siegrist and Eberle [13].
Brie£y, the treated cells were washed and dissolved
in 0.85 N KOH by sonication. Absorbance was mea-
sured in a BioRad model 3550 microplate reader at
405 nm. The absorbance values were compared to
the standard curve obtained with synthetic melanin
dissolved and diluted in 0.85 N KOH.
2.4. Morphology
The changes in morphology and melanin content
in B16 cells cultured in a medium with MPB were
documented by microphotography.
2.5. Assay of tyrosinase activity
Tyrosinase activity was measured by the method
of Oikawa et al. [14] using L-[3,5-3H]tyrosine (1.85
TBq/mmol, Du Pont, Wilmington, DE, USA). The
B16 cells were plated at a density of 3U104 cells/well
on 12-well multi-plates (Coster, No. 3512, Cam-
bridge, MA, USA) and cultured for 24 h. The me-
dium was replaced with fresh medium containing L-
[3H]tyrosine (18.5 kBq/ml) and the cells were treated
with 4^120 WM MPB and cultured for an additional
48 h. After incubation, the medium (0.5 ml) was
mixed with 10% trichloroacetic acid (0.5 ml) and
centrifuged. The supernatant was treated with 50Fig. 1. Chemical structure of MPB.
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mg of Norit SX-3 (Sigma), the mixture was again
centrifuged, and the supernatant was passed through
a ¢lter (0.22 Wm pore size; Millipore, Tokyo, Japan).
The radioactivity of the ¢ltrate containing tritiated
water derived from L-[3H]tyrosine was counted in a
liquid scintillation counter (LC-3500, Aloka, Tokyo,
Japan).
2.6. Assay of cAMP
The B16 cells (2U103), plated on 24-well multi-
plates (Falcon, No. 3047), were cultured for 96 h.
The medium was replaced with fresh FBS-free me-
dium containing 0.1% bovine serum albumin and
2 mM 3-isobutyl-1-methylxanthine. After treating
for 30 min with 10 nM MSH or 4^120 WM MPB,
cellular cAMP was measured using the Yamasa RIA
kit (Yamasa, Tokyo, Japan).
2.7. Determination of tyrosinase mRNA
B16 cells were seeded at a density of 3U104 cells
per T-75 £ask (Falcon, No. 3024) in 20 ml MEM
containing 10% FBS, 1% NEAA and antibiotics.
After cell attachment (24 h) 4^120 WM MPB was
added and cultured for 24^72 h at 37‡C. The cells
were then washed twice with phosphate bu¡ered sa-
line. Total RNA was extracted using RNA Zol (Bio-
tecx Laboratories, Houston, TX, USA), and mRNA
was isolated from total RNA using the Dynabeads
mRNA puri¢cation kit (Dynal A.S., Oslo, Norway).
Detection and analysis of gene expression at the
mRNA level were performed using GeneAmp Ther-
mostable rTth Reverse Transcriptase RNA PCR kit
(TaKaRa, Osaka, Japan). Brie£y, 20 Wl of reverse
transcription (RT) reaction mixture containing
mRNA, isolated from 75 Wg of total RNA, was in-
cubated at 70‡C for 15 min using 5 U of rTth DNA
polymerase in the presence of 1 mM MnCl2 and 0.75
WM antisense primer. After the RT reaction, the
products were held at 95‡C for 2 min. Polymerase
chain reaction (PCR) ampli¢cation was performed
by adding 0.6 mM EGTA, 1.5 mM MgCl2 and
0.15 WM sense primer. The sequences of the sense
and antisense primers for tyrosinase were 5P-
TTCAAAGGGGTGGATGACCG-3P and 5-PGAC-
AVCATAGTAATGCATCC-3P, respectively, as re-
ported by Jackson et al. [15]. The ampli¢cation of
the same mRNA with murine L-actin primers con-
¢rmed that equal amounts of mRNA were reverse-
transcribed. The sequences of primers for L-actin
were 5P-TCAGAAGGACTCCTATGTGG-3P (sense)
and 5P-TCTCTTTGATGTCACGCACG-3P (anti-
sense) as reported by Yokoi et al. [16]. The mixture
was ampli¢ed with the program temperature control
system PC-700 (ASTEC, Fukuoka, Japan). The am-
pli¢cation pro¢le was 35 cycles of denaturation at
95‡C for 1 min, primer annealing at 55‡C for
1 min, and extension at 72‡C for 1 min. At the end
of the cycles, the reaction was continued at 72‡C for
7 min. The PCR products were electrophoresed in
1.5% agarose gel, stained with ethidium bromide
and visualized under UV light. The product size of
the tyrosinase gene and L-actin gene obtained by
PCR were 341 and 500 bp, respectively.
2.8. Assay of growth inhibition
The B16 cells (1U104) were plated on a 96-well
multi-plate (Falcon, No. 3072), and the treatment
was started after 1 day by addition of various drugs.
Cell proliferation was monitored at various stages by
measuring the amount of water-soluble formazan
dye using the method of Ishiyama et al. [17].
2.9. Protein assay
Protein was measured using the BCA protein assay
kit (Pierce, Rockford, IL, USA).
3. Results
3.1. Stimulation of dendrite formation by MPB
B16 cells were usually round to polygonal (Fig.
2A, colony; and Fig. 2D, at con£uency). In contrast,
when treated with 120 WM MPB, their perinuclear
cytoplasmic area was reduced within 12 h (Fig.
2B), and maximal extension of dendritic processes
was usually observed after 48 h along with darkening
to the top of the dendrites (Fig. 2C). Similar mor-
phological changes and melanin formation are ob-
served when B16 cells are treated with 120 WM
MPB for 48 h under a subcon£uent layer (Fig.
2D,E).
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3.2. E¡ect of MPB on the melanin formation
The in£uence of MPB on the melanin formation,
one of the most characteristic markers of di¡erentia-
tion of B16 cells, was examined (Fig. 3). The time-
and dose-dependent stimulatory actions on melanin
formation by MPB were observed at 4^120 WM for
24^96 h. The amount of melanin was greater when
treated with more than 40 WM of MPB for 96 h, than
that induced by 10 nM MSH.
Table 1
E¡ect of MPB on cAMP production in B16 melanoma cells
Treatment Intracellular cAMP (nmol/mg protein)
Control 0.30 þ 0.03
MSH 10 WM 5.10 þ 0.46
MPB 4 WM 0.33 þ 0.03
MPB 12 WM 0.31 þ 0.04
MPB 40 WM 0.28 þ 0.05
MPB 120 WM 0.27 þ 0.05
Values are expressed as mean þ S.D. (n = 4). Data are represen-
tative of three experiments.
Fig. 2. E¡ect of MPB on B16 melanoma cell dendricity. (A) B16 melanoma cells cultured in the control medium show round to poly-
gonal morphology. (B) B16 melanoma cells exposed to 120 WM MPB for 12 h began to exhibit dendrite outgrowth. (C) B16 melano-
ma cells exposed to 120 WM MPB for 48 h exhibit increased dendricity, longer dendrites and more branching of the dendrites. Mela-
nin accumulation in the cytoplasmic area and at the top of the dendrites is evident. (D) B16 melanoma cells cultured in the control
medium (con£uent). (E) Subcon£uent B16 melanoma cell layer treated with 120 WM MPB for 48 h also exhibit increased dendricity
and melanin accumulation. (All ¢gures, U200, original magni¢cation.)
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3.3. E¡ect of MPB on tyrosinase activity
As shown in Fig. 4, MSH-stimulated tyrosine oxi-
dation in a 48-h culture of B16 cells was about six
times greater than that in the control. MPB stimu-
lated tyrosine oxidation in a dose-dependent manner
from 12 to 120 WM concentration.
3.4. Intracellular cAMP level after treatment with
MPB
The amount of intracellular cAMP was measured
by radioimmunoassay after exposing B16 cells to 4^
120 WM MPB. During 30 min incubation there was
no increase in the intracellular cAMP level which
remained at the control level of 0.3 nmol/mg protein.
In contrast, addition of MSH (10 nM) markedly in-
creased the amount of cAMP to 5.1 nmol/mg protein
(Table 1).
Fig. 6. E¡ect of MPB on the growth of B16 melanoma cells
measured by the water-soluble formazan dye method. MPB
concentrations were (WM): 0 (E, control) ; 4 (8), 12 (F), 40
(a), 120 (b). The data shown are the means of quadruplication.
Inset: the growth inhibitory curve obtained by B16 melanoma
cells cultured with 4^120 WM for 96 h. The IC50 value was
20 WM.
Fig. 5. Induction of tyrosinase mRNA in B16 melanoma cells
by MPB. B16 melanoma cells were cultured with 12, 40 or 120
WM MPB for 24^72 h. Total RNA was extracted using RNA
Zol, and RT-PCR analysis was performed as described in Sec-
tion 2. Lane 1; control, lane 2; 40 WM MPB for 24 h, lane 3;
40 WM MPB for 48 h, lane 4; 40 WM MPB for 72 h, lane 5;
12 WM MPB for 48 h, lane 6; 40 WM MPB for 48 h, lane 7;
120 WM for 48 h.
Fig. 4. E¡ect of MPB on tyrosinase activity in B16 melanoma
cells. B16 melanoma cells were cultured for 48 h in the presence
of 4^120 WM MPB or 10 nM MSH. Data are means þ S.D.
(n = 4).
Fig. 3. E¡ect of MPB on melanin formation in B16 melanoma
cells. B16 melanoma cells were cultured for 24^96 h in the pres-
ence of 4^120 WM MPB or 10 nM MSH. Data are
means þ S.D. (n = 4). MPB concentrations were (WM): 0 (E,
control) ; 4 (8) ; 12 (F) ; 40 (a) ; 120 (b). 10 nM MSH (O).
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3.5. E¡ect of MPB on the expression of tyrosinase
mRNA
The e¡ect of MPB on tyrosinase mRNA expres-
sion was examined using RT-PCR. As shown in Fig.
5, tyrosinase mRNA was detected 24, 48 and 72 h
after MPB (40 WM) stimulation. Expression of tyro-
sinase mRNA was observed by the treatment with
12^120 WM MPB for 48 h in a dose-dependent man-
ner. On the other hand, there was no change in the
level of L-actin mRNA.
3.6. E¡ect of MPB on the growth of B16 cells
Fig. 6 shows the time course of cell growth moni-
tored by the water-soluble formazan dye method.
The addition of 12^120 WM MPB for 48^96 h sig-
ni¢cantly inhibited the growth of B16 cells. At 96 h
incubation the IC50 concentration was approximately
20 WM (Fig. 6, inset).
3.7. E¡ects of various protein kinase inhibitors of
MPB-induced melanogenesis
Table 2 shows the e¡ects of KT-5720, H-89 and H-
7 on MPB-induced melanogenesis. MPB-induced
melanogenesis was strongly inhibited by the addition
of potent and selective cAMP-dependent protein ki-
nase inhibitors, KT-5720 [18] and H-89 [19]. In con-
trast, protein kinase C inhibitor, H-7 [20], showed no
inhibitory activity against MPB-induced melanogen-
esis. H-85, as a negative control of H-89 [19], did not
inhibit MPB-induced melanogenesis. MSH-induced
melanogenesis was also inhibited by the addition of
KT-5720. KT-5720 or H-85 alone did not a¡ect mel-
anogenesis in B16 melanoma cells (data not shown).
4. Discussion
In this paper, we have determined the e¡ect of
MPB on the di¡erentiation of B16 cells using the
following indicators: (1) morphological changes,
(2) melanogenesis and (3) growth inhibitory action.
As described in Section 3, 12 h of MPB treatment
induces rapid and extensive dendricity in B16 cells,
similar to the morphology of normal melanocytes.
Stimulation of melanin synthesis at 48 h was ob-
served as well as a potent dose-dependent growth
inhibition by MPB. A similar sequence of events
has been reported for human melanocytes and B16-
F1 cells treated with keratinocyte-conditioned me-
dium (KCM) [4] or with endothelin-1 [21]. Here
also, the dendrite-like structures were observed prior
to the stimulation of melanogenesis.
It is of interest to know whether actin ¢bers are
involved in dendrite formation in pigment cells. In
this regard, Lacour et al. [4] reported that disruption
of actin micro¢laments by cytochalasin B blocked
dendrite formation in B16 cells treated with KCM,
suggesting that polymerization of actin ¢bers relates
to dendrite formation. During the period of dendrite
formation, mRNA levels for L-actin as well as L-
tubulin were unchanged in KCM-treated cells. We
also found that L-actin mRNA levels remained un-
changed in MPB-treated cells during the period of
dendrite formation. Thus, MPB as well as KCM-
treated cells could form dendrites without the induc-
tion of actin mRNA.
Melanogenesis in B16 cells can be induced by
MSH, cAMP and its analogues [5,22,23], phospho-
diesterase inhibitors [24], forskolin [25] and Rho in-
activation [26]. These data suggest that the cAMP-
protein kinase A signal transduction pathway is in-
volved in the melanogenic response. Stimulation of
melanogenesis in B16 cells by MPB, however, was
independent of cAMP production and was due to
an increase in tyrosinase activity which correlated
with increased tyrosinase mRNA. Similar results
were obtained from experiments with imidazole-
Table 2
E¡ects of protein kinase inhibitors on MPB-induced melano-
genesis
Treatment Intracellular melanin
(Wg/mg protein)
Control 17.8 þ 1.0
MPB (40 WM) 88.5 þ 3.7
MPB (40 WM)+KT5720 (2 WM) 38.7 þ 3.8
MPB (40 WM)+H-89 (10 WM) 30.2 þ 9.1
MPB (40 WM)+H-85 (10 WM) 79.2 þ 10.6
MPB (40 WM)+H-7 (10 WM) 92.3 þ 9.9
MSH (10 nM) 45.8 þ 2.5
MSH (10 nM)+KT5720 (2 WM) 19.8 þ 5.7
Values are expressed as mean þ S.D. (n = 4). Data are represen-
tative of three experiments.
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treated B16/C3 cells [8], suggesting that imidazole
acts at the pretranslation level.
In our study, selective protein kinase A inhibitors
inhibited MPB-induced melanogenesis, while protein
kinase C inhibitor did not. These results strongly
suggest that MPB-induced melanogenesis is related
to protein kinase A at the post-cAMP production
level in the cell. It is extremely interesting to know
whether the di¡erentiation induced by MPB repre-
sents a direct control of the structural tyrosinase
gene or is mediated through the regulation of protein
kinase A.
Melanogenesis is part of the melanocyte-speci¢c
defensive system against environmental stress such
as UV radiation [27]. In our previous experiments,
MPB was shown to induce fragmentation of nucleoli
with inhibition of ribosomal RNA synthesis in HeLa
cells and to have anti-viral activity [10^12]. Since
such activities probably result in stress to B16 cells,
MPB-induced melanogenesis could also be a kind of
response to the cellular stress induced by MPB. Fur-
ther studies are needed to clarify the relationship
between MPB-induced melanogenesis and nucleolus
segregation.
Melanogenesis in melanoma cells and melanocytes
is regulated by various factors [28^30]. By using
MPB, melanogenesis and its regulation in melanoma
cells can be studied to elucidate new steps in pigment
formation and cell di¡erentiation.
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